AU687324B2 - Stretch resistant vaso-occlusive coils - Google Patents

Description

Patents Act 1990 TARGET THERAPEUTICS, INC.

ORIGINAL

COMPLETE SPECIFICATION STANDARD PATENT Inuertioi. Title: Stretch i'esi'Stuii1 alSo-oCC1i( 'eC0il8 Tfhe following statement is a full dlescription of this invention including the best method of performing it known to us:- RELATED APPLICATIONS This is a continuation-in-part of U.S. 08/717,285, filed September 1996 which in turn is a continuation-in-part of 08/607,593, filed February 27, 1996 and 08/497,331, filed June 30, 1995, the entirety of which are incorporated by reference.

FIELD OF THE INVENTION This invention is an implantable vaso-occlusive device. It is typically a vaso-occlusive coil comprising a primary helically wound coil which may then be wound into a secondary shape. Central to the invention is the use of a stretchresisting member extending through the lumen formed, which stretch-resisting member is fixedly attached, directly or indirectly, to the coil in at least two locations. The stretch resisting member is preferably somewhat loose within the interior of the lumen so to prevent the coil from collapsing, binding, and therefore stiffening dunng passage of turns through the human body. The coil should bend easily. In some variations of the invention, the stretch-resisting member may be formed into coil tips at the ends of the coil using simple equipment such as soldering irons or the like. The tips are typically of the same diameter as is the coil body itself. This stretch-resisting member is for the primary purpose of preventing stretching of the coil during movement of that coil, by retrieval or repositioning after deployment. The device may have a self-forming secondary shape made from a pre-formed primary linear helically wound coil, although it need not have the secondary form. Desirably, the coil is extremely flexible and is controllaby released using a severable or mechanical joint such as an lectrolytically detachable joint. External fibers may be attached to the device and affixed to the pre-formed linear member to increase thrombogenicity. The extremely flexible variation of the invention may be hydraulically delivered S/

I

through the lumen of a catheter and is so flexible that it may be retrievably delivered therethrough a flow-directed catheter. The vaso-occlusive member may be also be covered with a fibrous braid. The device is typically introduced into the body through a catheter. The device is passed axially through the catheter sheath and assumes its secondary form upon exiting the catheter.

BACKGROUND OF THE INVENTION Vaso-occlusion devices are surgical implements or implants that are placed within the vasculature of the human body, typically via a catheter, either to block the flow of blood through a vessel making up that portion of the vasculature via the formation of an embolus or to form such an embolus within an aneurysm stemming from the vessel. One widely used vaso-occlusive device is a helical wire coil having windings which may be dimensioned to engage the walls of the vessels. Other less stiff, helically coiled devices have been described, as well as those involving woven braids. Virtually all such vaso-occlusive implants are delivered by wire-guided catheters which devices are pushed through the catheter.

Because of the need for a pusher and concerns for recovery of such vaso-occlusive devices should they be malplaced m the body, it is unlikely that prior to this 'invention has there been a vaso-occlusive device of a form similar to this 20 delivered through a flow directed catheter.

As an instance of an early vaso-occlusive device, US Patent No 4,994,069, to Ritchart et al., describes a vaso-occlusive coil that assumes a linear helical configuration when stretched and a folded, convoluted configuration when relaxed. The stretched condition is used in placing the coil at the desired site (by its passage through the catheter) and the coil assumes a relaxed configuration which is better suited to occlude the vessel once the device is so placed Ritchart et al. describes a variety of shapes. The secondary shapes of the disclosed coils include "flower" shapes and double vortices. A random secondary shape is described, as well.

Vaso-occlusive coils having attached fibrous elements in a variety of secondary shapes are shown in US Patent No. 5,304,194, to Chee et al. Chee et al.

describes a helically wound device having a secondary shape in which the fibrous elements extend in a sinusoidal fashion down the length of the coil. These coils, as with Ritchart et al., are produced in such a way that they will pass through the lumen of a catheter in a generally straight configuration and, when released from the catheter, form a relaxed or folded shape in the lumen or cavity chosen within the human body. The fibrous elements shown in Chee et al. enhance the ability of the coil to fill space within the vasculature and to facilitate formation of embolus and subsequent allied tissue.

There are a variety of ways of discharging shaped coils and linear coils into the human vasculature. In addition to those patents which apparently describe only the physical pushing of a coil out into the vasculature Ritchart et there are a number of other ways to release the coil at a specifically chosen time and site. US Patent No. 5,354,295 and its parent, 5,122,136, both to Guglielmi et al., describe an electrolytically detachable embolic device.

A variety of mechanically detachable devices are also known. For instance, US Patent No. 5,234,437, to Sepetka, shows a method of unscrewing a helically wound coil from a pusher having interlocking surfaces. US Patent No.

5,250,071, to Palermo, shows an embolic coil assembly using interlocking clasps mounted both on the pusher and on the embolic coil US Patent No. 5,261,916, to Engelson, shows a detachable pusher-vaso-occlusive cK!. assembly having an interlocking ball and keyway-type coupling. US Patent No. '5,'04,195, to Twyford et al., shows a pusher-vaso-occlusive c:ll assembly having an affixed, proximally extending wire carrying a ball on its proximal end and a pusher having a similar end. The two ends are interlocked and discr""ige when expelled from the distal tip of the catheter. US Patent No. 5,31 to Palermo, also shows a method for discharging numerous coils from a single pusher by use of a guidewire which has a section capable of interconnecting with the interior of the helically wound coil. US Patent No 5,350,397, to Pa,_inn et al, shows a pusher having a throat at its distal end and a pusher through its axis. The pusher sheath will hold onto the end of an cmbolic coil and will then be released upon pushing the axially placed pusher wire against the member found on the proximal end of the vasoocclusive coil.

Vaso-occlusive coils having little or no inherent secondary shape have also been described. For instance, in US Patent Application 07/978,320, filed November 18, 1992, entitled "Ultrasoft Embolization Coils with Fluid-Like Properties" by Berenstein et al., is found a coil having little or no shape after introduction into the vascular space.

None of these devices are helical coils which contain a stretch-resisting member contained therein.

SUMMARY OF THE INVENTION This invention is a vaso-occlusive device comprising a helically wound coil which is formed by winding a wire into a first or primary helix to formafd outer helical member having first and second ends A stretch resistan ember extending through the lumen thus-formed is fixedly attached, di'ctly or indirectly, to the coil in at least two locations. The stretc resisting member is preferably loose within the coil to prevent binding the coil during passage of S 20 the coil through turns in the vasculature.

The primary helix may be woup nto a secondary form and heat-treated to preserve that form, desirably prio f the step of including the stretch-resisting member into the coil. The.,scondary form may be one which, when ejected from a delivery catheter, fps a specific shape. Such a shape might, fill a vascular cavituch as an aneurysm, or perhaps, a fistula or AVM. The stiffness of the v us parts of the coil may be tailored to enhance the utility of the device fo pecific applications Extremely flexible coils are highly desirable. Fibrous materials may be woven into the member or tied or wrapped onto it to enhance the thrombogenicity SUMMARY OF THE INVENTION This invention is a vaso-occlusive device comprising: an outer helically wound primary coil having a first end and a second end, defining a lumen between said first end and second end, and having a flexibility such that one centimeter will flex more than about 20° when held horizontally; (ii) a stretch-resisting polymeric member extending through said lumen and fixedly attached to said primary coil in at least two locations, and (iii) a deployment tip attached to at least one of said first end or said second end and said deployment tip comprises an electrolytically detachable end adapted to detach from a pusher by imposition of an electric current on said pusher.

The stretch-resisting member is preferably loose within the coil to prevent binding of the coil during passage of the coil through turns in the 15 vasculature.

The primary helix may be wound into a secondary form and heattreated to preserve that form, desirably prior to the step of including the stretch-resisting member into the coil. The secondary form may be one which. when ejected from a delivery catheter, forms a specific shape. Such a 20 shape might, fill a vascular cavity such as an aneurysm, or perhaps, a fistula or AVM. The stiffness of the various parts of the coil may be tailored to enhance the utility of the device for specific applications. Extremely flexible coils are highly desirable. Fibrous materials may be woven into the member or tied or wrapped onto it to enhance the thrombogenicity.

0 a «0 The device is used simply by temporarily straightening the device, as necessary, and introducing it into a suitable catheter, the catheter already having been situated so that its distal opening is at the selected site in the body. The device is then pushed through the catheter and, upon its ejection from the distal end of the catheter into the vascular cavity, assumes its relaxed or secondary shape.

The device is typically used in the human vasculature to form emboli but may be used at any site in the human body where an occlusn such as one produced by the inventive device is needed.

Also forming an important aspect of this invention is the combination of this inventive vaso-occlusive device with a flow-directed catheter.

BRIEF DESCRIPTION OF THE DRAWINGS Figure 1A shows a side view, partial cutaway of a vaso-occlusive coil made according to the invention having a generally linear fibrous stretch-resisting member.

Figure IB shows a side view, partial cutaway of a vaso-occlusive coil made according to the invention having a generally linear wire stretch-resisting member.

20 Figure 1C shows a side view, partial cutaway of a vaso-occlusive coil made according to the invention having a generally helical stretch-resisting member.

Figures 2A, 2B, and 2C show side view, partial cutaways of typical ends of the inventive vaso-occlusive coils.

Figures 3A, 3B, and 3C show sidc view rutaways of electrolytically severable joints in combination with a vaso-occlusive coil made according to the invention.

Figures 4A and 4B show a side view, partial cutaway of a typical mechanically detachable joint in combination with a vaso-occ!usive coil made according to the invention.

Figure 5 shows a shaped secondary configuration for the inventive vaso-occlusive device.

Figure 6 shows a clover-leaf secondary shape for the inventive vasoocclusive device.

Figure 7 shows a double-looped secondary shape for the inventive vasoocclusive device.

Figure 8 shows attachment of external fibrous material to the inventive vaso-occlusive device.

Figure 9 shows attachment of external braided fibrous material to the inventive vaso-occlusive device.

Figure 10 shows the combination of the vaso-occlusive device of this invention in assembly with a flow-directed catheter.

Figures 1 IA-1 ID show a procedure for introducing a vaso-occlusive coil such as found in the other Figures into an aneurysm.

DESCRIPTION OF THE INVENTION Figures IA, 1B, and 1C show side-view partial cross-sections (or cutaways) of highly desirable variations of the inventive coil (100, 200, 210).

"The variations shown i Figures IA and 1B are made up of a helically wound outer coil (102, 202) having a first end (104, 204) and a second end (106, 206). We refer to this form as the as the "primary" winding or shape. These 9 variations include a stretch-resisting member (108, 208, 214) which is shown to be fixedly attached both to the first end (104, 204) and to the second end (106, 206). In certain circumstances, it may be desirable to attach the stretch-resisting member (108, 208) only to one of the two ends, to at least one site between the to ends, or to neither of the two ends. Clearly, for attaining stretch resistance, the stretch resisting member must be attached to at least two points on the coil.

The stretch-resisting member (108) of the variation shown in Figure 1A is fibrous and desirably polymeric. The stretch-resisting member (108) may be thermoplastic or thermosetting and comprise a bundle of threads or a single filament melted onto, glued, or otherwise fixedly attached to the vaso-occlusive coil (100). In some instances, it may also be desirable to include one or more metallic strands m the stretch-resisting member (108) to provide stiffness or electrical conductance for specific applications.

The stretch-resisting member (208) of the variation shown in Figure 1B is a simple wire or "ribbon" which is soldered, brazed, glued, or otherwise fixedly attached to the first end (204), second end (206), or to the coil at one or more locations intermediate to those the ends.

The variation shown in Figure 1C includes a stretch-resisting member (214) which is comprised of a helically wound coil which is soldered, brazed, glued, or otherwise fixedly attached to the first end (204) or second end (206) or in one or more intermediate locations. The stretch-resisting member (214) in this configuration provides a greater measure of lateral flexibility than the wire variation (208 in Figure 1B). It may be wound in either the same direction as is 15 the outer coil (202) or in the alternate direction. A modest drawback to this variation is that it will stretch more than the Figure I B variation when axially e* stressed.

The materials used in constructing the vaso-occlusive coil (102, 202) and the stretch resisting member (108, 208, 214) may be any ofa wide variety of materials; preferably, a radio-opaque material such as a metal or a polymer is used. Suitable metals and alloys for the wire making up the primary coil (102, 202) and the stretch-resisting member (108, 208, 214) include the Platinum Group metals, especially platinum, rhodium, palladium, rhenium, as well as tungsten, gold, silver, tantalum, and alloys of these metals. These metals have significant radio-opacity and in their alloys may be tailored to accomplish an appropriate blend of flexibility and stiffness. They are also largely biologically inert Highly preferred is a platinum/tungsten alloy, 8% tungsten ai. the remainder platinum.

The ribbon or coil stretch-resisting members (208, 214) may also be of any of a wide variety of stainless steels if some sacrifice of radio-opacity and flexibility may be tolerated. Very desirable materials of construction, from a mechanical point of view, are materials which maintain their shape despite being subjected to high stress. Certain "super-elastic alloys" include various nickel/titanium alloys (48-58 atomic nickel and optionally containing modest amounts of iron); copper/zinc alloys (38-42 weight zinc); copper/zinc alloys containing 1-10 weight of beryllium, silicon, tin, aluminum, or gallium; or nickel/aluminum alloys (36-38 atomic aluminum). Particularly preferred are the alloys described in US Patent Nos. 3,174,851, 3,351,463, and 3,753,700.

Especially preferred is the titanium/nickel alloy known as "nitinol". These are very sturdy alloys which will tolerate significant flexing without deformation even when used as very small diameter wire.

If a super-elastic alloy such as nitinol is used in the device, the diameter of the coil wire may be significantly smaller than that used when the relatively more ductile platinum or platinum/tungsten alloy is us.d as the matenal of construction 15 The coils may be made ofradiolucent fibers or polymers (or metallic threads coated with radiolucent or radio-opaque fibers) such as Dacron (polyester), polyglycolic acid, polylactic acid, fluoropolymers (polytetrafluoroethylene), Nylon (polyamide), or even cotton or silk. Should a polymer be used as the major component of the vaso-occlusive coil member, it is desirably filled with some amount of a radio-opaque material such as powdered tantalum, powdered tungsten, bismuth oxide, barium sulfate, and the like.

The coil material is first wound into a primary coil (102, 202). The primary coil is typically linear after it has been wound. Generally speaking, when the coil (102, 202) is a metallic coil and that coil is a platinum alloy or a superelastic alloy such as amtinol, the diameter of the wire used in the production of the coil (102, 202) will be in the range of 0.00025 and 0.006 inches. The wire is wound into a primary coil (102, 202) having a primary diameter of between 0 003 and 0.025 inches. For most neurovascular indications, the preferable primary coil (102, 202) diameter is 0.008 to 0.018 inches. We have generally found that the coil wire may be of sufficient diameter to provide a hoop strength to the resulting device sufficient to hold the device in place within the chosen body site, lumen or cavity, without substantially distending the wall of the site and without moving from the site as a result of the repetitive fluid pulsing found in the vascular system. However, this inventive concept allows the user to utilize extremely flexible coil assemblies having very high packing efficiencies. For instance, coil wires having wire diameters of 0.0001 5" and less are suitable for such highly flexible devices. Typically the coil diameter will be 0.015" and less. They will "droopl. more than about 200, preferably 350 to 90° when about 1 centimeter of the primary form of the coil having a free end is held horizontally.

The axial length of the primary coil will usually fall in the range of 0.5 to 100 cm, more usually 2.0 to 40 cm. Depending upon usage, the coil may well have 10-75 turns per centimeter, preferably 10-40 turns per centimeter. All of the dimensions here are provided only as guidelines and are not critical to the .**.invention. However, only dimensions suitable for use in occluding sites within S 15 the human body are included in the scope of this invention.

Once the primary coil (102, 202) is wound, the stretch-resisting member (108, 208) is inserted into the lumen of the primary coil (102, 202) and secured to the coil as desired. Ends (104, 204, 106, 206) are preferably of the same diameter .as is the primary coil (102, 202).

Suitable polymeric materials for the polymeric stretch-resisting member (108) can be either thermosetting or thermoplastic. Thermoplastics are preferred because they allow simplification of the procedure for constructing the device (100) since they may be melted and formed into the end or ends (104, 106).

Simple devices such as soldering irons may be used to form the ends.

Thermosetting plastics would typically be held in place by an adhesive. Suitable polymers include most biocompatible materials which may be made into fibers but include thermoplastics, polyesters such as polyethyleneterephthalate (PET) especially Dacron; polyamides including the Nylons; polyolefins such as polyethylene, polypropylene, polybutylenc, their mixtures, alloys, block and random copolymers; polyglycolic acid; polylactic acid; fluoropolymers (polytetrafluoro-ethylene), or even silk. Preferred because of the long history of safe and effective usage in the human body are fibrous PET (sold as Dacron) and polypropylene. Highly preferred is polypropylene.

Figure 2A shows a side-view partial cross-section of one end of inventive coil (100). Figure 2A also shows the helically wound outer coil (102) having an end (106) which is formed from a formerly molten fiber which also makes up the strctch-rcsisting member (114). An end of this type may be considered to have modestly higher vaso-occluding properties than a metallic end. Other functional equivalents to this structure include ends (106) formed of glues such as epoxies and their equivalents, and which are mechanical in nature.

Figure 2B shows an external knot (112) which fixes the length of the coil member (102) and keeps it from stretching; Figure 2C shows a reformed mass of ***formerly molten polymer or of glue which is of a diameter larger than the inner S diameter of coil (102) and prevents the coil from stretching. The knot (112) and 15 block (114) are not shown to be attached to the col (102) but may be.

The variations shown in Figures 1A, 1B, 1C and 2A, 2B, and 2C are designed to be deployed by use of a pusher and a catheter in the manner discussed in Ritchart et al, discussed above. Other methods (and concomitant fixtures or joints to accomplish those methods) may also be used.

For instance, the end of the device may be adapted to accept an electrolytically severable joint of the type discussed in US Patent No. 5,354,295 and its parent, 5,122,136, both patents to Guglielmi and Sepctka, described above.

Figures 3A and 3B depict, in partial cross section, such variations. The vasoocclusive coil (130, 230) is attached to a fill member or bushing (132, 232). The fill member or bushing (132, 232) preferably comprises a thermoplastic formed into place or an epoxy or the like and adheres, in turn, both to the stretch resistant member (134, 234) and the core wire (136, 236). The stretch-resisting member (134, 234) is thusly indirectly attached to the vaso-occlusive coil (130, 230) via the fill member or bushing (132, 232). The core wire (136, 236) in this variation has an enlarged member which is embedded in the fill member (132, 232). The core wire (136, 236) is insulated, typically with a combination of polytetrafluoroethylene and PARYLENE (polyparaxyxylene), except for a small sacrificial joint (138, 238) which is intended to be the site of the electrolysis as the joint (138, 238) is eroded or severed and the coil deployed into the body site. The details of this variation (sans stretch-resistant member (136, 236)) are discussed in Gia et al, US Patent application Serial No. 08/367,061, filed December 30, 1994, the entirety of which is incorporated by reference.

Figure 3C shows an especially preferred variation of the inventive device.

The assembly (131) employs a stretch-resisting member (133) which is connected indirectly to the coil (135). Specifically the stretch-resisting member (133) is a thermoplastic fiber or fibers which are melted to form a coil tip (137) at one end of the coil (135) and is looped about a hook (139) at (or in the vicinity of) the other end of the coil (135). An anchor coil (141) is coaxially situated between the vaso-occlusive coil (135) and the pusher wire (136). The hook (139) forms the 15 final turn or half-turn of the anchor coil (141). The stretch-resisting member (133) is thusly indirectly attached to the vaso-occlusive coil (135) via the anchor coil (141). The anchor coil (141) and the vaso-occlusive coil (135) are preferably welded together.

Figure 3C also shows the vaso-occlusive coil (135) in its maximum stretched condition. The stretch-resisting member (133) is shown resisting further axial stretching of the assembly. When the vaso-occlusive coil (135) is not stretched, the stretch-resisting member (133) would obviously be loose, i.e., normally longer than the lumen, in the lumen of the assembly (131). If the stretch-resisting member (133) is not allowed to have such a loose axial fit, the adjacent turns of the coil (135) would "bottom" against each other during passage through turns in the vasculature and cause the assembly (131) to become stiff.

Figure 4A shows still another variation of a joint for releasing the inventive coil into a site within the human body. In this instance, the joint is mechanically deployed. The primary coil (140) incorporates interlocking clasps, one (142) located on an end of the coil (140) and one (144) located on the end of a pusher (146). The stretch-resisting member (148) is attached to the interlocking clasp (142) via a filler block (154). Again, the filler block (154) comprises a material a thermoplastic or adhesive material) which may be placed in the coil and will adhere to the stretch-resistant member (148). The coil assembly (150), made up of the primary coil (140), interlocking clasp (142), and stretchresisting member (148) is deployed by retracting catheter body (or sheath) (152).

Figure 4B shows a variation of the device depicted in Figure 4A which does not employ special filler block material (154) for adhering to the stretch-resistant member.

Other mechanically deployable joints suitable for use with the inventive coil are described in: US Patent No. 5,234,437, to Scpctka, (shows a method of unscrewing a helically wound coil from a pusher having interlocking surfaces).

15 US Patent No. 5,250,071, to Palermo, (shows an embolic coil assembly using interlocking clasps mounted both on the pusher and on the embolic coil) V US Patent No. 5,261,916, to Engelson, (shows a detachable pusher/vaso-occlusive coil assembly having an interlocking ball and keyway-type coupling) US Patent No. 5,304,195, to Twyford et al. (shows a pusher-vasoocclusive coil assembly having an affixed, proximally extending wire carrying a ball on its proximal end and a pusher having a similar end, which two ends are interlocked and disengage when expelled from the distal tip of the catheter) US Patent No. 5,312,415, to Palermo (also shows a method for discharging numerous coils from a single pusher by use of a guidewire which has a section capable of interconnecting with the interior of the helically wound coil).

US Patent No. 5,350,397, to Palermo et al. (shows a pusher having a throat at its distal end and a pusher through its axis. The pusher sheath will hold onto the end of an embolic coil and will then be released upon pushing the axially placed pusher wire against the member found on the proximal end of the vaso-occlusive coil).

The entirety of which are incorporated by reference.

As was noted above, the devices of this invention may have the simple linear shape shown in Figures 1 and 2 or may have shapes which are not so simple. Figures 5, 6, and 7 show what are termed "secondary" shapes in that they are formed from the primary coil by the simple act of winding the piimary coil on a form of a desired shape and then heat treating the so-formed shape. Figure shows a shaped coil assembly (160) having a stretch-resistant member (162).

Figure 6 shows a clover-leaf shaped coil assembly (164) also having a stretchresistant member (162). Figure 7 shows a double-loop coil assembly (166).

15 These are indicative of the various secondary shapes suitable for this invention.

Additionally, these inventive devices may also be used in conjunction with Svarious external fiber adjuncts. Figure 8 shows a partial side-view of a linear variation of the inventive device (170) having filamentary material (172) looping through u:e coil (174). This method of attachment is described in greater detail in US Pat. Nos. 5,226,911 and 5,304,194, to Chee et al, the entirety of which are incorporated by reference. A further description of a desirable fiber attachment is ~shown in US Pat. application No. 08/265,188, to Mirigian et al, filed June 24, 1994.

V Figure 9 shows a partial cutaway of a device (180) having a braided covering (182) of a filamentary material and a stretch-resisting member (184).

This method of enveloping a coil is described in greater detail in US Pat. Nos.

5,382,259. to Phelps et al, the entirety of which is incorporated by reference.

The fibrous woven or braided tubular materials may be made from a biocompatible materials such as Dacron (polyester), polyglycolic acid, polylactic acid, fluoropolymers (polytetrafluoroethylene), Nylon (polyamide), or silk The strands forming the braid should be reasonably heavy, having tensile strength of greater than about 0.15 pounds. The materials mentioned, to the extent that they are thermoplastics, may be melted or fused to the coils. Alternatively, they may be glued or otherwise fastened to the coils. Preferred materials include Dacron.

Figure 10 shows a highly preferred assembly incorporating a number of desirable aspects of the invention. Specifically, the very flexible variation of the inventive vaso-occlusive device noted above, wherein the vaso-occlusive device is capable of "drooping" 200 or more and having a polymeric stretchresisting member included therein, is especially suitable for inclusion in a flowdirected catheter and particularly when used with an electrolytically severable joint. Figure 10 shows the flow-directed catheter (200) containing a verv flexible vaso-occlusive coil (202) as described above and utilizing a similarly flexible strain-resistant member (204). The flow directed catheter (200) may have a distal 15 radio-opaque marker (206) if so desired.

Proximally of the vaso-occlusive coil (202) is a connective wire (208) which is insulated at all points proximal of the electrolytic joint (210).

The flow directed catheter (200) may be of any known design such as is found, in U.S. Pat. No. 5,336,205, to Zenzen et al, the entirety of which is incorporated by reference. "Flow-directed catheters" are directed to the treatment site in the human body through the vasculature by the motive power of natural blood flow The more distal segments of flow-directed catheters are often of materials having significant elastomeric properties but with high burst strengths, polyurethane, polyvinylchloride, silicones, etc. They are often quite "rubbery" in feel. Consequently, flow directed catheters are not usually especially suitable for use with guidewires and the like.

In use of this variation of the vaso-occlusive device, however, since the vaso-occlusive device is so compliant and able to be delivered using hydraulic pressure alone (as with saline), they may be used with flow-directed catheters.

Further, since the vaso-occlusive device (202) contains a stretch-resisting member (204), the vaso-occlusive device (202) may be withdrawn into the catheter (200) using the connective wire (208).

The connective wire (208) used therein should be very flexible so not to interfere with the movement of the catheter (200). It is conductive and iri.lated proximally of the electrolytic joint (210). Introduction of an electric current into the connective wire (208) will cause the electrolytic joint (210) to erode and the vaso-occlusive device (202) to become detached. Complete description of the operation of such a device is found in U.S. Patent Nos. 5,122,136 and 5,354,295, both to Guglielmi and Sepetka.

Figures 11A-1 ID depict a common deployment method for introduction of the inventive vaso-occlusive devices described here. It may be observed that these procedures are not significantly different than those described in the Ritchart et al.

patent mentioned above. Specifically, Figure 11A shows the distal tip of a delivery catheter (310) which is within the opening (312) of an aneurysm (314) 15 found in an artery (316). The distal or end section of the vaso-occlusive device (318) is shown within the catheter (310). In Figure 11B, the distal end portion of the vaso-occlusive device (318) has ex: ie distal end of the catheter (310) and has wound into a secondary shape within the aneurysm (314). Figure 11 C shows the completion of the formation of the secondary shape within the aneurysm (314). Figure 1 1D shows the separation of the vaso-occlusive device (318) from the pusher, placement within the aneurysm (314), and the withdrawal of the catheter from the mouth of the aneurysm.

Once the inventive coil is in place in an aneurysm or other site, there may be an occasion during which the coil must be moved or even withdrawn. For instance, in Figure 11D, the coil might extend through the mouth (312) of the aneurysm into the artery. Occlusion would not be desirable in the artery. A device such as the endovascular snare shown in US Pat No. 5,387,219, to Rappe, may then be used to grasp the exposed coil and move it or retrieve it from the body. The stretch-resisting member of this invention prevents the coil from stretching into a single strand of wire and multiplying in length.

Modification of the above-described variations of carrying out the invention that would be apparent to those of skill in the fields of medical device design generally, and vaso-occlusive devices specifically, are intended to be within the scope of the following claims.

eee* e* s e..

e *e

Claims (16)

1. A vaso-occl usixe device comprising: an outer helically wound primary coil having a first end aolnd a second end. defining a luinen be[ween said first end andl secoind endl, and having a flexibilit such that one cent imteor will flex more than about 20' when held horizontally: (ii) a stretch-resisting polymeric niemiber extending through said lumnll and fixedly attached to said primary coil in at least two locations. and (iii) a deploynment tip attached to at least one of said first end or said second end and said deplovyment tip comprises an electrolytically detachable end adapted to detach from a piusher bY imuposition of an electric current onil said pushier.

2. The device of claim 1 wherein said strotch-resisting member comprises at least one fiber.

3. The device of claimi I wherein said stretch-resisting member comprises multiple fibers.

4. The device of claiiii I where the device has a secondary form.

5. The device of claim 1 wherein said helically wound coil comprises a mnietal selected from the group consisting of platinumn. palladiumi. rhlodium. gold. tungsten, and alloys of one or more of thliese metals. :56. 0. The device of claiim 5 xwheroin said helically wound coil comprises Sall alloy of platinum and tungsen.

7. The device of claim I additionally conprising external filamentary material attached to said primnlay coil.

8. The device of claiiii 1 wherein the stretch-resisting member comprises a thernoplaslic.

9. The device of claim 8 wherein said thermoplastic comprises polyethylene terephthalale.

10. The device of claiiii 8 wherein said thermoplastic conlmprises polypropylene.

11. Thie device of claim 8 wherein said thermoplastic also formnis a cap at located on at least one end of said primary coil.

12. The device of claim 1 wherein the stretch-resisting iimemniber ad heres to at least one end of said primary coil.

13. 'Ili (Uice of (Jan11i I I wliei'ii ill i ap~ is of' 11lw saliiiu diaii wter als salid prllimarIy coil. 14. 'Ilie dlevice, of, claiml I I xvlei said I lwriiio 1 tlstic; forms caps at b)oth ends of said primalry coiL Thle device of claimi I whereinl thle st 10tcli-i csis ti iliui meber ex tends t hrough said luimen and is fixedlyV, idirectly at tachied to at least onle of said fir'st end and second m11(1.

16. The device of claiiii I whereil I lhe stret(l-rosistiiig ni(11enl. extend~s through said lumen aildi is fixedly. directly attachied to at least one of'said first end and second ends.

17. T1he device of claim I wvherein the stretch-resisting mlemb~er is loose wvithin the l umen of said helically wound coil.

18. The device of claini 1 further comprising an anchor coil located coaxially within [he lumen of thie helically wouind coil at at least one end of saidi helically wvound coil.

19. The device of claim 18 wherein the s tretcli-resis ting nienber is fixedly attached to said anchor coil. The device of claim 19 wherein thle stireitch-rosis ting niziiber is fixedly attached to a hook onl said anchor coil. *21. The device of clainm 1 further comprising inl combination a flow- directed catheter surrounding at least a portion of said lielically wound pimlary coil. Datied this fifth day of November 1997 1'ARGETTHJEPELT1C:S. INC, Patent Attoric ys for the Applicant: T'XJ. RICE S& C O. ABSIRACT OF THE INVENTION This is an implantable vaso-occlusive device. It is typically a vaso- occlusive coil comprising a primary helically wound coil which may then be wound into a secondary shape. Central to the invention is the use of a stretch- resisting member extending through the lumen formed, which stretch -resisting member is fixedly attached, directly or indirectly, to the coil in at least two locations. The stretch resisting member is preferably somewhat loose within the interior of the lumen so to prevent the coil from collapsing, binding, and therefore stiffening during passage of turns through the human body. The coil should bend easily. In some variations of the invention, the stretch-resisting member may be formed into coil tips at the ends of the coil using simple equipment such as soldering irons or'the like. The tips are typically of the same diameter as is the coil body itself. This stretch-resisting member is for the primary purpose of preventing stretching of the coil during movement of that coil, by retrieval or 15 repositioning after deployment. The device may have a self-forming secondary shape made from a pre-formed primary linear helically wound coil, although it need not have the secondary form. Desirably, the coil is extremely flexible and is controllaby released using a severable or mechanical joint such as an electrolytically detachable joint. External fibers may be attached to the device and affixed to the pre-formed linear member to increase thrombogenicity. The extremely flexible variation of the invention may be hydraulically delivered through the lumen of a catheter and is so flexible that it may be retrievably delivered therethrough a flow-directed catheter. The vaso-occlusive member may be also be covered with a fibrous braid. The device is typically introduced into the body through a catheter. The device is passed axially through the catheter sheath and assumes its secondary form upon exiting the catheter